The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper says executives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback